MindMetrix

MindMetrix sits at the intersection of digital health, neuroscience, wellness, and sports performance. Its described offerings cover two distinct use cases: myflow applies pupil-based neurofeedback to mental-state regulation for athletes, while its 2025 adolescent assessment targets clinical providers and evaluates more than 40 mental-health conditions. This combination gives the company a broader application range than a single-purpose athlete-training product, but it also makes its market positioning less focused. In the sports-performance segment, the stated differentiator is real-time pupil feedback linked to brain arousal; in provider-facing assessment, the stated distinction is the inclusion of both adolescent and caregiver insights. MindMetrix is an early-stage, privately held company founded in 2022, with four recorded funding events and no disclosed round amounts.

MindMetrix’s recorded development shows a progression from early support to a wider set of product applications. Founded in 2022, it recorded a pre-seed round on October 1 of that year, followed by non-equity assistance involving Swissnex San Francisco on June 27, 2023. A second pre-seed round was announced on April 29, 2024, when multiple investors were associated with the round, including Venture Kick, SICTIC, Serpentine Ventures, and individual investors. Product activity became more visible in 2024 with the announcement of a comprehensive online mental-health assessment. In June 2025, MindMetrix launched an adolescent assessment for providers; the following month, NewBeginnings Integrated Healthcare selected the company’s offering. The company also describes myflow, a neurofeedback product for athletes.